MeTA FIP workshop programme

616 views
530 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
616
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • MeTA FIP workshop programme

    1. 1. 69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice A workshop co-organised by MeTA (Medicine Transparence Aliance) and FIP FIP-WHO META Istanbul, Turkey September 5, 2009
    2. 2. FIP-WHO META Istanbul, Turkey September 5, 2009 Workshop objectives: 1. To inform FIP and interested Congress participants about the Medicines Transparency Alliance (MeTA) and its concept of transparency. 2. To discuss how transparency can be applied in pharmacy practice, especially in developing countries. 3. To strengthen professional links between MeTA and FIP.
    3. 3. Timetable <ul><li>09:05-09:15 Opening. Ton HOEK, FIP General Secretary </li></ul><ul><li>09:15-09:30 MeTA and its concept of Transparency : Identification of priority areas. W. BANNENBERG, MeTA Technical Director. </li></ul><ul><li>09:30-10:00 KEYNOTE SPEECH: N. LEYESA, Phil.Pharm.Ass. </li></ul><ul><li> Transparency and Pharmaceutical Practice in a MeTA country: The MeTA Philippines country report. </li></ul><ul><li>10:00-10:20 Group Discussion. </li></ul><ul><li>10:20-10:45 Coffee break </li></ul><ul><li>10:45-11:00 Plenary session and Panel discussion. </li></ul><ul><li>W. Bannenberg, T. Wuliji; X. Hao Chan; B. Becan,; A. Álvarez-Risco; S. Boyaci, M. Bin Shahna </li></ul><ul><li>11:55-12:00 Summary and closure. </li></ul>FIP-WHO META Istanbul, Turkey September 5, 2009
    4. 4. 69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice GROUP AND PLENARY DISCUSSION FIP-WHO META Istanbul, Turkey September 5, 2009
    5. 5. 3 QUESTIONS <ul><li>Q1: Is increased transparency and accountability (e.g. in pricing, in information on quality, in disclosure of objective information) essential to improve access to medicines? </li></ul>FIP-WHO META Istanbul, Turkey September 5, 2009
    6. 6. 3 QUESTIONS <ul><li>Q2: What are the main changes to be introduced in pharmacy supply chains (from manufacture to patient) for them to become more transparent? </li></ul>FIP-WHO META Istanbul, Turkey September 5, 2009
    7. 7. 3 QUESTIONS <ul><li>Q3: Do we believe good pharmacy practice guidelines should include an element of transparency and accountability? </li></ul>FIP-WHO META Istanbul, Turkey September 5, 2009
    8. 8. 3 Questions: <ul><li>Is increased transparency and accountability (e.g. in pricing, in information on quality, in disclosure of objective information) essential to improve access to medicines? </li></ul><ul><li>What are the main changes to be introduced in pharmacy supply chains (from manufacture to patient) for them to become more transparent? </li></ul><ul><li>Do we believe good pharmacy practice guidelines should include an element of transparency and accountability? </li></ul>FIP-WHO META Istanbul, Turkey September 5, 2009
    9. 9. 69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice Panel Discussion FIP-WHO META Istanbul, Turkey September 5, 2009
    10. 10. Panel Discusion <ul><li>Wilbert BANNENBERG, Technical Director, MeTA. </li></ul><ul><li>Tana WULIJI, Human Resources and Pharmacy Education, FIP. </li></ul><ul><li>Xuan HAO CHAN, Professional and Scientific Affairs, Project Officer, FIP. </li></ul><ul><li>Bulent BECAN, Turkish Pharma Association of Research Based Companies. </li></ul><ul><li>Aldo ÁLVAREZ RISCO, South American Network of Pharmaceutical care, Peru. </li></ul><ul><li>Serif BOYACI, Turkish Association of Pharmacists. </li></ul><ul><li>Mohamed BIN SHAHNA, WHO. </li></ul>FIP-WHO META Istanbul, Turkey September 5, 2009

    ×